A cautionary note on entry and exit strategies with long-acting cabotegravir and rilpivirine

被引：0
|
作者：
Ripamonti, Diego [1 ,5 ]
Rusconi, Stefano [2 ,3 ]
Zazzi, Maurizio [4 ]
机构：
[1] ASST Papa Giovanni XXIII, Infect Dis Unit, Bergamo, Italy
[2] Univ Milan, Legnano Gen Hosp, ASST Ovest Milanese, Infect Dis Unit, Milan, Italy
[3] Univ Milan, DIBIC Luigi Sacco, Milan, Italy
[4] Univ Siena, Dept Med Biotechnol, Siena, Italy
[5] ASST Papa Giovanni XXIII, Bergamo, Italy
来源：
AIDS | 2024年 / 38卷 / 02期
关键词：
HIV;
D O I：
10.1097/QAD.0000000000003760
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：263 / 265
页数：3
相关论文
共 50 条
  • [1] Appropriateness of virological monitoring with long-acting injectable cabotegravir and rilpivirine
    Ripamonti, Diego
    Borghetti, Alberto
    Zazzi, Maurizio
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (10) : 2720 - 2724
  • [2] Long-Acting Cabotegravir and Rilpivirine: Innovation, New Challenges, and Opportunities
    Llibre, Josep M.
    Kuritzkes, Daniel A. R.
    [J]. CLINICAL INFECTIOUS DISEASES, 2023, 76 (09) : 1655 - 1657
  • [3] Experiences to date with the logistical management of long-acting cabotegravir and rilpivirine
    Johnson, Kamile
    Sawkin, Mark T.
    [J]. DRUGS IN CONTEXT, 2022, 11
  • [4] Are we ready for long-acting? A feasibility evaluation of long-acting cabotegravir-rilpivirine in clinical practice
    Borghetti, Alberto
    Farinacci, Damiano
    Ciccullo, Arturo
    Dusina, Alex
    Moschese, Davide
    Iannone, Valentina
    D'Angelillo, Anna
    Lombardi, Francesca
    Delle Donne, Valentina
    Massaroni, Valentina
    Visconti, Elena
    Tamburrini, Enrica
    Di Giambenedetto, Simona
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (10) : 4970 - 4974
  • [5] Effect of Obesity on the Exposure of Long-acting Cabotegravir and Rilpivirine: A Modeling Study
    Bettonte, Sara
    Berton, Mattia
    Stader, Felix
    Battegay, Manuel
    Marzolini, Catia
    [J]. CLINICAL INFECTIOUS DISEASES, 2024, 79 (02) : 477 - 486
  • [6] The future of long-acting cabotegravir plus rilpivirine therapy: deeds and misconceptions
    Rusconi, Stefano
    Santoro, Maria M.
    Capetti, Amedeo F.
    Gianotti, Nicola
    Zazzi, Maurizio
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2022, 60 (03)
  • [7] Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression
    Swindells, Susan
    Andrade-Villanueva, Jaime-Federico
    Richmond, Gary J.
    Rizzardini, Giuliano
    Baumgarten, Axel
    Masia, Mar
    Latiff, Gulam
    Pokrovsky, Vadim
    Bredeek, Fritz
    Smith, Graham
    Cahn, Pedro
    Kim, Yeon-Sook
    Ford, Susan L.
    Talarico, Christine L.
    Patel, Parul
    Chounta, Vasiliki
    Crauwels, Herta
    Parys, Wim
    Vanveggel, Simon
    Mrus, Joseph
    Huang, Jenny
    Harrington, Conn M.
    Hudson, Krischan J.
    Margolis, David A.
    Smith, Kimberly Y.
    Williams, Peter E.
    Spreen, William R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (12): : 1112 - 1123
  • [8] Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine
    Daryl Hodge
    David J. Back
    Sara Gibbons
    Saye H. Khoo
    Catia Marzolini
    [J]. Clinical Pharmacokinetics, 2021, 60 : 835 - 853
  • [9] Long-Acting Cabotegravir/Rilpivirine Concentrations in Combination With Intravenous Rifampin: A Case Report
    Sunagawa, Shawnalyn W.
    Havens, Joshua P.
    Podany, Anthony
    Walker, Bryan
    Scarsi, Kimberly K.
    Bares, Sara H.
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (12):
  • [10] Characterization of a case of virological failure after switch to long-acting cabotegravir and rilpivirine
    Mazzitelli, Maria
    Avolio, Antonio
    Carandina, Riccardo
    Parisi, Saverio
    Wensing, Annemarie
    Cattelan, Annamaria
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (08) : 2074 - 2076
12345